|
1
|
Cohn JN, Ferrari R and Sharpe N: Cardiac
remodeling - concepts and clinical implications: a consensus paper
from an international forum on cardiac remodeling. Behalf of an
International Forum on Cardiac Remodeling. J Am Coll Cardiol.
35:569–582. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Biernacka A and Frangogiannis NG: aging
and cardiac fibrosis. Aging Dis. 2:158–173. 2011.PubMed/NCBI
|
|
3
|
Leask A: Potential therapeutic targets for
cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF,
partners in fibroblast activation. Circ Res. 106:1675–1680. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Osadchii OE: Cardiac hypertrophy induced
by sustained beta-adrenoreceptor activation: pathophysiological
aspects. Heart Fail Rev. 12:66–86. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nichtova Z, Novotova M, Kralova E and
Stankovicova T: Morphological and functional characteristics of
models of experimental myocardial injury induced by isoproterenol.
Gen Physiol Biophys. 31:141–151. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ozaki M, Kawashima S, Yamashita T, Hirase
T, Ohashi Y, Inoue N, Hirata K and Yokoyama M: Overexpression of
endothelial nitric oxide synthase attenuates cardiac hypertrophy
induced by chronic isoproterenol infusion. Circ J. 66:851–856.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith RS Jr, Agata J, Xia CF, Chao L and
Chao J: Human endothelial nitric oxide synthase gene delivery
protects against cardiac remodeling and reduces oxidative stress
after myocardial infarction. Life Sci. 76:2457–2471. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park JY, Shin HK, Choi YW, Lee YJ, Bae SS,
Han J and Kim CD: Gomisin A induces Ca2+-dependent
activation of eNOS in human coronary artery endothelial cells. J
Ethnopharmacol. 125:291–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park JH, Lee S, Cho DH, Park YM, Kang DH
and Jo I: Far-infrared radiation acutely increases nitric oxide
production by increasing Ca(2+) mobilization and
Ca(2+)/calmodulin-dependent protein kinase II-mediated
phosphorylation of endothelial nitric oxide synthase at serine
1179. Biochem Biophys Res Commun. 436:601–606. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gail MH, Boone CW and Thompson CS: A
calcium requirement for fibroblast motility and prolifertion. Exp
Cell Res. 79:386–390. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gees M, Colsoul B and Nilius B: The role
of transient receptor potential cation channels in Ca2+
signaling. Cold Spring Harb Perspect Biol. 2:a0039622010.
View Article : Google Scholar
|
|
12
|
Thilo F, Liu Y, Schulz N, Gergs U, Neumann
J, Loddenkemper C, Gollasch M and Tepel M: Increased transient
receptor potential vanilloid type 1 (TRPV1) channel expression in
hypertrophic heart. Biochem Biophys Res Commun. 401:98–103. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marshall NJ, Liang L, Bodkin J,
Dessapt-Baradez C, Nandi M, Collot-Teixeira S, Smillie SJ, Lalgi K,
Fernandes ES, Gnudi L and Brain SD: A role for TRPV1 in influencing
the onset of cardiovascular disease in obesity. Hypertension.
61:246–252. 2013. View Article : Google Scholar
|
|
14
|
Ma S, Li D, Yang D, Tan Y, Tang B, Jin F,
Jiang S, Li X and Yang Y: Establishment of a conditional transgenic
mouse model expressing human uncoupling protein 2 in vascular
smooth muscle cells. Exp Ther Med. 4:545–547. 2012.PubMed/NCBI
|
|
15
|
Ma S, Yang D, Wang K, Tang B, Li D and
Yang Y: Cryptotanshinone attenuates isoprenaline-induced cardiac
fibrosis in mice associated with upregulation and activation of
matrix metal-loproteinase-2. Mol Med Rep. 6:145–150.
2012.PubMed/NCBI
|
|
16
|
Mukai Y, Rikitake Y, Shiojima I, Wolfrum
S, Satoh M, Takeshita K, Hiroi Y, Salomone S, Kim HH, Benjamin LE,
et al: Decreased vascular lesion formation in mice with inducible
endothelial-specific expression of protein kinase Akt. J Clin
Invest. 116:334–343. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong
J, He H, Zhao Z, Cao T, Yan Z, et al: Activation of TRPV1 by
dietary capsaicin improves endothelium-dependent vasorelaxation and
prevents hypertension. Cell Metab. 12:130–141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma S, Yang D, Li D, Tang B, Sun M and Yang
Y: Cardiac extracellular matrix tenascin-C deposition during
fibronectin degradation. Biochem Biophys Res Commun. 409:321–327.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Q, Ma S, Li D, Zhang Y, Tang B, Qiu
C, Yang Y and Yang D: Dietary capsaicin ameliorates pressure
overload-induced cardiac hypertrophy and fibrosis through the
transient receptor potential vanilloid type 1. Am J Hypertens.
27:1521–1529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Andresen MC and Peters JH: TRPV1,
hypertension, and cardiovascular regulation. Cell Metab.
12:421author reply 422. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao JF, Ching LC, Kou YR, Lin SJ, Wei J,
Shyue SK and Lee TS: Activation of TRPV1 prevents OxLDL-induced
lipid accumulation and TNF-α-induced inflammation in macrophages:
role of liver X receptor α. Mediators Inflamm. 2013:9251712013.
View Article : Google Scholar
|
|
22
|
Ohanyan VA, Guarini G, Thodeti CK,
Talasila PK, Raman P, Haney RM, Meszaros JG, Damron DS and Bratz
IN: Endothelin-mediated in vivo pressor responses following TRPV1
activation. Am J Physiol Heart Circ Physiol. 301:H1135–H1142. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suri A and Szallasi A: The emerging role
of TRPV1 in diabetes and obesity. Trends Pharmacol Sci. 29:29–36.
2008. View Article : Google Scholar
|
|
24
|
Motter AL and Ahern GP: TRPV1-null mice
are protected from diet-induced obesity. FEBS Lett. 582:2257–2262.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L and Wang DH: TRPV1 gene knockout
impairs postischemic recovery in isolated perfused heart in mice.
Circulation. 112:3617–3623. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhong B and Wang DH: TRPV1 gene knockout
impairs preconditioning protection against myocardial injury in
isolated perfused hearts in mice. Am J Physiol Heart Circ Physiol.
293:H1791–H1798. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang W, Rubinstein J, Prieto AR, Thang LV
and Wang DH: Transient receptor potential vanilloid gene deletion
exacerbates inflammation and atypical cardiac remodeling after
myocardial infarction. Hypertension. 53:243–250. 2009. View Article : Google Scholar
|
|
28
|
Huang W, Rubinstein J, Prieto AR and Wang
DH: Enhanced postmyocardial infarction fibrosis via stimulation of
the transforming growth factor-beta-Smad2 signaling pathway: role
of transient receptor potential vanilloid type 1 channels. J
Hypertens. 28:367–376. 2010. View Article : Google Scholar
|
|
29
|
Ren JY, Song JX, Lu MY and Chen H:
Cardioprotection by ischemic postconditioning is lost in isolated
perfused heart from diabetic rats: involvement of transient
receptor potential vanilloid 1, calcitonin gene-related peptide and
substance P. Regul Pept. 169:49–57. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Li L, Hua Y, Nunn JM, Dong F,
Yanagisawa M and Ren J: Cardiac-specific knockout of ET(A) receptor
mitigates low ambient temperature-induced cardiac hypertrophy and
contractile dysfunction. J Mol Cell Biol. 4:97–107. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao F, Liang Y, Wang X, Lu Z, Li L, Zhu S,
Liu D, Yan Z and Zhu Z: TRPV1 activation attenuates high-salt
diet-induced cardiac hypertrophy and fibrosis through PPAR-δ
upregulation. PPAR Res. 2014:4919632014. View Article : Google Scholar
|
|
32
|
Buckley CL and Stokes AJ: Mice lacking
functional TRPV1 are protected from pressure overload cardiac
hypertrophy. Channels (Austin). 5:367–374. 2011. View Article : Google Scholar :
|
|
33
|
Horton JS, Buckley CL and Stokes AJ:
Successful TRPV1 antagonist treatment for cardiac hypertrophy and
heart failure in mice. Channels (Austin). 7:17–22. 2013. View Article : Google Scholar
|
|
34
|
Ge W, Yuan M, Ceylan AF, Wang X and Ren J:
Mitochondrial aldehyde dehydrogenase protects against doxorubicin
cardiotoxicity through a transient receptor potential channel
vanilloid 1-mediated mechanism. Biochim Biophys Acta. 1862:622–634.
2016. View Article : Google Scholar
|
|
35
|
Bhuiyan MS, Shioda N and Fukunaga K:
Chronic beta-AR activation-induced calpain activation and impaired
eNOS-Akt signaling mediates cardiac injury in ovariectomized female
rats. Expert Opin Ther Targets. 13:275–286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Belge C, Hammond J, Dubois-Deruy E,
Manoury B, Hamelet J, Beauloye C, Markl A, Pouleur AC, Bertrand L,
Esfahani H, et al: Enhanced expression of β3-adrenoceptors in
cardiac myocytes attenuates neurohormone-induced hypertrophic
remodeling through nitric oxide synthase. Circulation. 129:451–462.
2014. View Article : Google Scholar
|
|
37
|
Savergnini SQ, Ianzer D, Carvalho MB,
Ferreira AJ, Silva GA, Marques FD, Peluso AA, Beiman M, Cojocaru G,
Cohen Y, et al: The novel Mas agonist, CGEN-856S, attenuates
isoproterenol-induced cardiac remodeling and myocardial infarction
injury in rats. PLoS One. 8:e577572013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bharti S, Singh R, Chauhan SS, Hussain T,
Al-Attas OS and Arya DS: Phosphorylation of Akt/GSK-3β/eNOS
amplifies 5-HT2B receptor blockade mediated anti-hypertrophic
effect in rats. FEBS Lett. 586:180–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liao Y, Asakura M, Takashima S, Ogai A,
Asano Y, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, et al:
Celiprolol, a vasodilatory beta-blocker, inhibits pressure
overload-induced cardiac hypertrophy and prevents the transition to
heart failure via nitric oxide-dependent mechanisms in mice.
Circulation. 110:692–699. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ching LC, Kou YR, Shyue SK, Su KH, Wei J,
Cheng LC, Yu YB, Pan CC and Lee TS: Molecular mechanisms of
activation of endothelial nitric oxide synthase mediated by
transient receptor potential vanilloid type s1. Cardiovasc Res.
91:492–501. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ching LC, Chen CY, Su KH, Hou HH, Shyue
SK, Kou YR and Lee TS: Implication of AMP-activated protein kinase
in transient receptor potential vanilloid type 1-mediated
activation of endothelial nitric oxide synthase. Mol Med.
18:805–815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Su KH, Lin SJ, Wei J, Lee KI, Zhao JF,
Shyue SK and Lee TS: The essential role of transient receptor
potential vanilloid s1 in simvastatin-induced activation of
endothelial nitric oxide synthase and angiogenesis. Acta Physiol
(Oxf). 212:191–204. 2014. View Article : Google Scholar
|
|
43
|
Guarini G, Ohanyan VA, Kmetz JG,
DelloStritto DJ, Thoppil RJ, Thodeti CK, Meszaros JG, Damron DS and
Bratz IN: Disruption of TRPV1-mediated coupling of coronary blood
flow to cardiac metabolism in diabetic mice: role of nitric oxide
and BK channels. Am J Physiol Heart Circ Physiol. 303:H216–H223.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kazakov A, Hall R, Jagoda P, Bachelier K,
Müller-Best P, Semenov A, Lammert F, Böhm M and Laufs U: Inhibition
of endothelial nitric oxide synthase induces and enhances
myocardial fibrosis. Cardiovasc Res. 100:211–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
